Tawasil, Monera F.
HRN: 22-53-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2024
CEFUROXIME 1.5GM (VIAL)
07/15/2024
07/22/2024
INTRAVENOUS
350 Mg IVTT
Every 8 Hours
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes